Santiago, Chile–(Newsfile Corp. – January 10, 2025) – Copperprotek USA, the U.S.-based division of Copperprotek SpA, announced FDA/FSIS GRAS (Generally Recognized As Safe) approval of its patented microparticle. The announcement has led to a U.S.-based industrial-scale testing period to launch in 2025. Copperprotek is a biotechnology research firm with 9+ years of experience that produces […]